Filing Details
- Accession Number:
- 0001494650-23-000101
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-12-20 12:20:16
- Reporting Period:
- 2023-12-15
- Accepted Time:
- 2023-12-20 12:20:16
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1494650 | Optinose Inc. | OPTN | Pharmaceutical Preparations (2834) | 421771610 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1502700 | Iii F Michael Marino | C/O Optinose, Inc. 1020 Stony Hill Road, Suite 300 Yardley PA 19067 | Chief Legal Officer & Corp Sec | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2023-12-15 | 3,817 | $0.00 | 338,516 | No | 4 | A | Direct | |
Common Stock | Disposition | 2023-12-18 | 5,005 | $1.15 | 333,511 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | A | Direct | |
No | 4 | S | Direct |
Footnotes
- Represents the vesting of performance-based restricted stock units (Performance RSUs) granted on March 6, 2020. Fifty percent (50%) of the Performance RSUs vested on June 15, 2022, upon achievement of certainmilestones in connection with the Company's development programs. The balance vests in eight equal quarterly installments, subject to continued service with the Issuer. Each Performance RSU represents the right toreceive one share of common stock of OptiNose, Inc.
- Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted share units under multiple award agreements. This sale ismandated by the issuer's award agreement under its equity incentive plan to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade bythe reporting person.